Department of Hepatobiliary Surgery and Transplantation, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Outpatient Centre, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Clin Transplant. 2018 Mar;32(3):e13205. doi: 10.1111/ctr.13205. Epub 2018 Feb 10.
Full-split liver transplantation (LTX) offers the possibility to expand the donor pool by utilization of one liver for two adults. The aim of our study was to analyze the long-term outcome in a large series and its applicability in the recent transplant era.
We performed a retrospective analysis of all full-split LTX from deceased donors (1999-2015). Additionally, the potential of full-split LTX was retrospectively analyzed in all whole organ LTX recipients between 2006 and 2015 (after introduction of the MELD allocation).
We performed 44 full-split LTX, thereof 82% before introduction of the MELD-based allocation system in Germany. Analysis showed highly selected recipients (median MELD score 8 points) and organ data (median donor age 30 years). 5- and 10-year patient survival rates after full-left and full-right LTX were 90.7%/90.7% and 85.2%/56.8% (P = .301), corresponding graft survival rates were 80.5%/80.5% in full-left grafts and 73.7%/36.8% in full-right graft (P = .198).
In the past, in case of strict donor and recipient selection, full-split LTX was a feasible method with a good outcome. Due to introduction of the national waiting list with a patient-oriented allocation based on the MELD score in 2006, full-split LTX seems to be not any longer applicable.
全离体肝移植(LTX)通过利用一个供肝为两个成人提供了扩大供体库的可能性。我们研究的目的是在一个大系列中分析其长期结果及其在最近移植时代的适用性。
我们对所有来自已故供体的全离体 LTX 进行了回顾性分析(1999-2015 年)。此外,我们还回顾性地分析了 2006 年至 2015 年期间所有接受全器官 LTX 的患者中全离体 LTX 的潜在应用(MELD 分配系统引入后)。
我们进行了 44 例全离体 LTX,其中 82%在德国引入基于 MELD 的分配系统之前进行。分析显示,受体选择非常严格(中位 MELD 评分 8 分),器官数据也非常好(中位供体年龄 30 岁)。全左和全右 LTX 后 5 年和 10 年患者生存率分别为 90.7%/90.7%和 85.2%/56.8%(P=0.301),全左移植物的相应移植物存活率为 80.5%/80.5%,全右移植物的存活率为 73.7%/36.8%(P=0.198)。
过去,在严格的供体和受体选择的情况下,全离体 LTX 是一种可行的方法,具有良好的结果。由于 2006 年引入了基于 MELD 评分的全国等候名单和以患者为中心的分配系统,全离体 LTX 似乎不再适用。